Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults

The objective of this study was to evaluate and compare both the safety and tolerability and the humoral and cell-mediated immune responses for two influenza virus subunit vaccines, one with MF59 adjuvant (Fluad) and one without an adjuvant (Agrippal), in healthy and in human immunodeficiency virus...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Durando, P., Fenoglio, D., Boschini, A., Ansaldi, F., Icardi, G., Sticchi, L., Renzoni, A., Fabbri, P., Ferrera, A., Parodi, A., Bruzzone, B., Gabutti, G., Podda, A., Del Giudice, G., Fragapane, E., Indiveri, F., Crovari, P., Gasparini, R.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology (ASM) 2008
Предметы:
Vaccine Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2238067/
https://ncbi.nlm.nih.gov/pubmed/18003811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00316-07
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы